LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.

Thepmankorn, Parisorn / Bach, John / Lasfar, Ahmed / Zhao, Xilin / Souayah, Sami / Chong, Zhao Zhong / Souayah, Nizar

Cytokine

2020  Volume 138, Page(s) 155404

Abstract: ... coronavirus 2 (SARS-CoV-2), can trigger a hyperinflammatory state characterized by elevated cytokine levels ... peripheral nervous systems have also been reported. This review discusses potential routes of SARS-CoV-2 neuroinvasion and ... may precipitate these complications. Clarification of the pathogenic mechanisms of SARS-CoV-2 is needed ...

Abstract The new coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can trigger a hyperinflammatory state characterized by elevated cytokine levels known as hypercytokinemia or cytokine storm, observed most often in severe patients. Though COVID-19 is known to be a primarily respiratory disease, neurological complications affecting both the central and peripheral nervous systems have also been reported. This review discusses potential routes of SARS-CoV-2 neuroinvasion and pathogenesis, summarizes reported neurological sequelae of COVID-19, and examines how aberrant cytokine levels may precipitate these complications. Clarification of the pathogenic mechanisms of SARS-CoV-2 is needed to encourage prompt diagnosis and optimized care. In particular, identifying the presence of cytokine storm in patients with neurological COVID-19 manifestations will facilitate avenues for treatment. Future investigations into aberrant cytokine levels in COVID-19 patients with neurological symptoms as well as the efficacy of cytokine storm-targeting treatments will be critical in elucidating the pathogenic mechanisms and effective treatments of COVID-19.
MeSH term(s) COVID-19/pathology ; COVID-19/therapy ; Central Nervous System/pathology ; Cerebrovascular Disorders/pathology ; Cerebrovascular Disorders/virology ; Cytokine Release Syndrome/pathology ; Cytokine Release Syndrome/therapy ; Cytokines/blood ; Humans ; Nervous System Diseases/pathology ; Nervous System Diseases/virology ; Peripheral Nervous System/pathology ; SARS-CoV-2
Chemical Substances Cytokines
Language English
Publishing date 2020-12-11
Publishing country England
Document type Journal Article ; Review
ZDB-ID 1018055-2
ISSN 1096-0023 ; 1043-4666
ISSN (online) 1096-0023
ISSN 1043-4666
DOI 10.1016/j.cyto.2020.155404
Shelf mark
Zs.A 2840: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top